Third Rock Ventures Launches Pliant Therapeutics with $45 Million Series A to Treat Fibrotic Diseases

Posted On: February 18, 2016

Third Rock Ventures, LLC today announced the formation of Pliant Therapeutics, Inc. with $45 million in Series A financing to discover and develop new therapies to treat the pathologic process of fibrotic disorders. By leveraging its powerful product engine based on recent biologic insights, Pliant Therapeutics has the potential to prevent or even reverse fibrosis […]

Read More